Sex-Specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus

Gender Medicine

Volumn 7, Issue 6, 2010, Pages 571-583

  Kautzky Willer, Alexandra ^a   Kamyar, Majid Reza ^b   Gerhat, Dora ^b   Handisurya, Ammon ^a   Stemer, Gunar ^a   Hudson, Stephen ^c   Luger, Anton ^a   Lemmens Gruber, Rosa ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

blood pressure; cardiovascular risk; diabetic complications; gender; lipid profile; type 2 diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; ANTIHYPERTENSIVE AGENTS; ASPIRIN; BLOOD GLUCOSE; BLOOD PRESSURE; BRAIN ISCHEMIA; CORONARY ARTERY BYPASS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PRIMARY PREVENTION; SECONDARY PREVENTION; SEX FACTORS;

EID: 78650857709     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2010.12.001     Document Type: Article

References (45)

1. GL Booth, MK Kapral, K Fung, and JV Tu Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: A population-based retrospective cohort study Lancet. 368 2006 29 36
2. DJ Wexler, RW Grant, and JB Meigs Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes Diabetes Care. 28 2005 514 520
3. A Juutilainen, S Kortelainen, and S Lehto Gender difference in the impact of type 2 diabetes on coronary heart disease risk Diabetes Care. 27 2004 2898 2904
4. R Huxley, F Barzi, and M Woodward Excess risk of fatal coronary heart disease associated with diabetes in men and women: Meta-analysis of 37 prospective cohort studies BMJ. 332 2006 73 78
5. PM Nilsson, H Theobald, G Journath, and T Fritz Gender differences in risk factor control and treatment profile in diabetes: A study in 229 Swedish primary health care centres Scand J Prim Health Care. 22 2004 27 31
6. M Kamyar, BJ Johnson, and JJ McAnaw Adherences to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus Pharm World Sci. 30 2008 120 127
7. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus http://whqlibdoc.who.int/hq/ 1999/WHO-NCD-NCS-99.2.pdf Accessed December 12, 2003
8. A Ernst, M Kinnear, and S Hudson Quality of prescribing: A study of guideline adherence of medication in patients with diabetes mellitus Pract Diab Int. 22 2005 285 290
9. Scottish Intercollegiate Guidelines Network (SIGN) Clinical guidelines-numerical list http://www.sign.ac.uk/guidelines/published/numlist. html Accessed October 20, 2010
10. American Diabetes Association Standards of medical care in diabetes-2008 Diabetes Care. 31 Suppl 1 2008 S12 S54
11. L Ryden, E Standl, M Bartnik Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Full text http://www.escardio.org/ guidelines-surveys/esc-guidelines/guidelinesdocuments/guidelines-diabetes-ft. pdf Accessed October 20, 2010
12. A Ferrara, CM Mangione, C Kim Translating Research Into Action for Diabetes Study Group Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes. Translating Research Into Action for Diabetes (TRIAD) Study Diabetes Care. 31 2008 69 74
13. MK Duggirala, RR Cuddihy, and MT Cuddihy Women with diabetes have poorer control of blood pressure than men J Womens Health (Larchmt). 14 2005 418 423
14. NF Chu, MM Lee, and DJ Wang The reappraisal of the association of glycosylated hemoglobin A1c (HbA1c) and blood pressure: A hypertension and diabetes study in a Taiwan rural area J Clin Epidemiol. 46 1993 173 179
15. J He, D Gu, J Chen GenSalt Collaborative Research Group Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study J Hypertens. 27 2009 48 54
16. A Pechre-Bertschi, and M Burnier Female sex hormones, salt, and blood pressure regulation Am J Hypertens. 17 2004 994 1001
17. M McDonald, RP Hertz, AN Unger, and MB Lustik Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older J Gerontol A Biol Sci Med Sci. 64 2009 256 263
18. JA Schmittdiel, A Traylor, and CS Uratsu The association of patient-physician gender concordance with cardiovascular disease risk factor control and treatment in diabetes J Womens Health (Larchmt). 18 2009 2065 2070
19. JF Reckelhoff Gender differences in the regulation of blood pressure Hypertension. 37 2001 1199 1208
20. D Conen, PM Ridker, and S Mora Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study Eur Heart J. 28 2007 2937 2943
21. RP Donahue, K Rejman, and LB Rafalson Sex differences in endothelial function markers before conversion to pre-diabetes: Does the clock start ticking earlier among women? The Western New York Study Diabetes Care. 30 2007 354 359
22. AI Adler, RJ Stevens, and A Neil UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes Diabetes Care. 25 2002 894 899
23. S Natarajan, Y Liao, and D Sinha Sex differences in the effect of diabetes duration on coronary heart disease mortality Arch Intern Med. 165 2005 430 435
24. I Gouni-Berthold, HK Berthold, and CS Mantzoros Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes Diabetes Care. 31 2008 1389 1391
25. L Trapani, and V Pallottini Age-related hypercholesterolemia and HMG-CoA reductase dysregulation: Sex does matter (a gender perspective) Curr Gerontol Geriatr Res 2010 420139
26. MJ Legato Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: Implications for therapy Am J Cardiol. 86 2000 15L 18L
27. J Liu, C Sempos, and RP Donahue Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes Diabetes Care. 28 2005 1916 1921
28. JE Hokanson, and MA Austin Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies J Cardiovasc Risk. 3 1996 213 219
29. D Preiss, and N Sattar Lipids, lipid modifying agents and cardiovascular risk: A review of the evidence Clin Endocrinol (Oxf). 70 2009 815 828
30. HN Ginsberg, MB Elam, LC Lovato ACCORD Study Group Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med. 362 2010 1563 1574 [published correction appears in N Engl J Med. 2010;362:1748]
31. LS Jnsdttir, N sson, and V Gudnason Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study J Cardiovasc Risk. 9 2002 67 76
32. A Kautzky-Willer, and A Handisurya Metabolic diseases and associated complications: Sex and gender matter! Eur J Clin Invest. 39 2009 631 648
33. PE Norman, WA Davis, DG Bruce, and TM Davis Peripheral arterial disease and risk of cardiac death in type 2 diabetes: The Fremantle Diabetes Study Diabetes Care. 29 2006 575 580
34. G Brevetti, R Bucur, and A Balbarini Women and peripheral arterial disease: Same disease, different issues J Cardiovasc Med (Hagerstown). 9 2008 382 388
35. HE Mulnier, HE Seaman, and VS Raleigh Risk of myocardial infarction in men and women with type 2 diabetes in the UK: A cohort study using the General Practice Research Database Diabetologia. 51 2008 1639 1645
36. M Crilly, P Bundred, and X Hu Gender differences in the clinical management of patients with angina pectoris: A cross-sectional survey in primary care BMC Health Serv Res. 7 2007 142
37. J Klimont, J Kytir, B Leitner Statistik Austria sterreichische Gesundheitsbefragung 2006/2007. Hauptergebnisse und methodische dokumentation http://www.statistik.at/web-de/static/oesterreichische-gesundheitsbefragung- 20062007-bericht-029865.pdf Accessed October 20, 2010
38. A Ferrara, DF Williamson, AJ Karter Diabetes (TRIAD) Study Group Sex differences in quality of health care related to ischemic heart disease prevention in patients with diabetes: The Translating Research Into Action for Diabetes (TRIAD) study, 2000-2001 Diabetes Care. 27 2004 2974 2976
39. U Smith, and EA Gale Does diabetes therapy influence the risk of cancer? Diabetologia 52 2009 1699 1708
40. M Jalving, JA Gietema, and JD Lefrandt Metformin: Taking away the candy for cancer? Eur J Cancer. 46 2010 2369 2380
41. L Mosca, LJ Appel, EJ Benjamin American Heart Association Evidence-based guidelines for cardiovascular disease prevention in women Circulation. 109 2004 672 693 (Pubitemid 38198877)
42. PM Ridker, NR Cook, and IM Lee A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N Engl J Med. 352 2005 1293 1304
43. T Wolff, T Miller, and S Ko Aspirin for the primary prevention of cardiovascular events: An update of the evidence for the U.S. Preventive Services Task Force http://www.annals.org/content/150/6/405.full Accessed November 1, 2010
44. G Ong, TM Davis, and WA Davis Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: The Fremantle Diabetes study Diabetes Care. 33 2010 317 321
45. L Welin, L Wilhelmsen, A Bjrnberg, and A Odn Aspirin increases mortality in diabetic patients without cardiovascular disease: A Swedish record linkage study Pharmacoepidemiol Drug Saf. 18 2009 1143 1149